Procalcitonin Antibody Market - Size, Share, Outlook, and Forecast till 2026

Procalcitonin (PCT) is a peptide precursor of 116 amino acids produced by parafollicular cells of the thyroid and neuroendocrine cells of lungs and intestine. It is used for synthesis of hormone calcitonin, which is involved in calcium homeostasis. The level of procalcitonin in blood increases as response to bacterial infection. The level of procalcitonin in the blood stream of healthy individuals is below the limit of detection (0.01 µg/L) of clinical assays. Procalcitonin antibodies are used as biomarker that exhibits greater specificity than proinflammatory markers (e.g. cytokines) for diagnosis of patients with sepsis and bacterial infections.

Increasing adoption of procalcitonin antibody for diagnosis of sepsis and other associated disorders is major factor fueling growth of the procalcitonin antibody market. Bacterial or microbial infections results into development of sepsis, which requires effective treatment and prognostic assessment. Conventional clinical laboratory methods for diagnosis of bacterial infections are either non-specific or require longer turnaround times, which is propelling demand for procalcitonin antibodies as biomarker to detect formation of sepsis. Furthermore, procalcitonin antibodies are used for carrying out various research tests such as ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Sandwich ELISA, and Western Blot, which is driving growth of the procalcitonin antibody market.

Key Developments of Procalcitonin Antibody Market

Market players offer procalcitonin antibodies for wide variety of applications in order to meet increasing demand from diagnostic centers and research and development industry. In February 2017, the US Food and Drug Administration (FDA) approved use of a rapid procalcitonin test to determine if antibiotics should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia and stopped in patients with sepsis. Furthermore, according to the new findings published in Critical Care Medicine, procalcitonin is an effective biomarker for infection and it can be used to determine antibiotic discontinuation in patients with suspected or confirmed sepsis, without causing adverse effects on outcomes.

Market players are engaged in developing novel diagnostics kits in order to maintain leading position in procalcitonin antibody market. In June 2018, Fujirebio Diagnostics received Food and Drug Administration (FDA) clearance for a new procalcitonin assay to be used on its Lumipulse G1200 immunoassay platform.Key players operating in procalcitonin antibody market include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo, Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, and Hotgen Biotech.

Global Custom Antibody Market Research Report 2018

Published Date : Jan 2019

Custom Antibody Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, German...

Global Antibody Drug Conjugates (Adc) Market Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Antibody Drug Conjugates (Adc) Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, N...

Asia-Pacific HER2 Antibody Market Report 2018

Published Date : Dec 2018

In this report, the Asia-Pacific HER2 Antibody market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2018 and 2026. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pc...

Asia-Pacific Antibody Market Report 2018

Published Date : Dec 2018

In this report, the Asia-Pacific Antibody market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2018 and 2026. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), reve...

Global Cancer Antibody Drug Conjugates Sales Market Report 2018

Published Date : Dec 2018

In this report, the global Cancer Antibody Drug Conjugates market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2018 and 2026. Geographically, this report split global into several key Regions, with sales...

United States Cancer Antibody Drug Conjugates Market Report 2017

Published Date : Oct 2017

In this report, the United States Cancer Antibody Drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven...

EMEA (Europe, Middle East and Africa) Hepatitis B Virus Core Antibody Diagnostic Kits Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Hepatitis B Virus Core Antibody Diagnostic Kits market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle ...

EMEA (Europe, Middle East and Africa) Antibody Drug Conjugates Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Antibody Drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With s...

Global Antibody Production Market

Published Date : Dec 2018

The global Antibody Productionmarket was valued at USD 7.42billion in 2016 and is projected to reach USD 21.04billionby 2025, growing at a CAGR of 12.28% from 2017 to 2025. Antibody production is a crucial part of biotechnology and drug development procedures in the R&D departments. With incr...

Global HER2 Antibody Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies HER2 Antibody in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers i...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.